News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
152 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28450)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (3178)
November (148)
Day
1 (167)
2 (22)
3 (10)
4 (48)
5 (185)
6 (145)
7 (156)
8 (155)
9 (41)
12 (152)
13 (137)
14 (135)
15 (192)
16 (43)
18 (37)
19 (172)
20 (163)
21 (127)
22 (143)
23 (101)
25 (36)
26 (231)
27 (174)
28 (122)
29 (195)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
4
5
6
7
8
9
12
13
14
15
16
18
19
20
21
22
23
25
26
27
28
29
30
Press Releases
New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn’s disease patient subgroups
October 12, 2026
·
14 min read
Press Releases
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn’s disease
October 12, 2026
·
14 min read
Press Releases
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
October 12, 2026
·
2 min read
Press Releases
Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026
October 12, 2026
·
3 min read
Press Releases
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
October 12, 2026
·
1 min read
Press Releases
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
October 12, 2026
·
1 min read
Press Releases
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
October 12, 2026
·
2 min read
Press Releases
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett’s Esophagus
October 12, 2026
·
10 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 12, 2026
October 12, 2026
·
1 min read
Press Releases
Teva to Host R&D Day on Wednesday, November 11 in New York City
October 12, 2026
·
3 min read
Previous
15 of 16
Next
